...
首页> 外文期刊>International journal of clinical oncology >Successful treatment of primary malignant lymphoma of the penis by organ-preserving rituximab-containing chemotherapy.
【24h】

Successful treatment of primary malignant lymphoma of the penis by organ-preserving rituximab-containing chemotherapy.

机译:保留器官的利妥昔单抗化疗成功治疗了阴茎原发性恶性淋巴瘤。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Primary penile lymphoma is extremely rare. Here we report the case of a 67-year-old man with the chief complaints of difficulty in urination and priapism, who was eventually diagnosed with primary malignant lymphoma of the penis. Pathological examination of excision biopsy of the left inguinal lymph node revealed malignant CD20+ diffuse large B-cell lymphoma. We treated this patient with a systemic rituximab-chemotherapy regimen and obtained good results, in terms of both functional and cosmetic outcomes. Soluble interleukin-2 receptor was a useful tumor marker for evaluating the therapeutic effect. The patient has been in remission for 10 months after the discontinuation of chemotherapy.
机译:原发性阴茎淋巴瘤极为罕见。在这里,我们报道了一名67岁男子的病例,该男子主要抱怨排尿困难和阴茎异常勃勃,最终被诊断出患有阴茎原发性恶性淋巴瘤。左腹股沟淋巴结切除活检的病理检查显示为恶性CD20 +弥漫性大B细胞淋巴瘤。我们用系统性利妥昔单抗化学疗法治疗了该患者,在功能和美容效果方面均取得了良好的效果。可溶性白介素2受体是评估疗效的有用肿瘤标志物。化疗终止后,患者已缓解10个月。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号